Previous 10 | Next 10 |
WILIMINGTON, Del., April 9, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX® in North America...
BioSpecifics Tech (NASDAQ: BSTC ): Q4 GAAP EPS of $1.00 beats by $0.06 . More news on: BioSpecifics Technologies Corp., Earnings news and commentary, Healthcare stocks news, Read more ...
WILIMINGTON, Del., March 16, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed as XIAFLEX ® in North...
Investing in the best growth stocks can generate superior returns over the long term. On the other hand, growth stocks are also particularly volatile and risky. The key, like usually happens, is separating the fundamentally sound companies from the ones with mediocre fundamentals. The follow...
BioSpecifics Tech (NASDAQ: BSTC ): Q3 GAAP EPS of $0.85 beats by $0.10 . More news on: BioSpecifics Technologies Corp., Earnings news and commentary, Healthcare stocks news, Read more ...
LYNBROOK, N.Y. , Nov. 8, 2019 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed as XIAFLEX® in the U.S. an...
Welcome to the Growth at a Reasonable Price screen for November. Generally, growth at a reasonable price is not an investment criterion for value investors, but these screens turn up stocks that can satisfy a stricter value investment filters. That being said, small-cap stocks are more lik...
LYNBROOK, N.Y. , Oct. 23, 2019 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class product marketed as XIAFLEX ® in the U.S. and Xiapex &...
LYNBROOK, N.Y. , Oct. 10, 2019 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed as XIAFLEX ® in the U.S. and ...
News, Short Squeeze, Breakout and More Instantly...
BioSpecifics Technologies Corp Company Name:
BSTC Stock Symbol:
NASDAQ Market:
BioSpecifics Technologies Corp Website:
Endo Announces Expiration Of Hart-Scott-Rodino Waiting Period For BioSpecifics Tender Offer PR Newswire DUBLIN, Nov. 18, 2020 DUBLIN , Nov. 18, 2020 /PRNewswire/ -- Endo International plc (Nasdaq: ENDP) (" Endo ") today announced the expiration of th...
New York, New York--(Newsfile Corp. - November 13, 2020) - Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether BioSpecifics Technologies Corp. (NASDAQ: BSTC) agreement to be acqui...
BioSpecifics Reports Third Quarter 2020 Financial and Operating Results - Endo acquisition of BioSpecifics expected to close in 4Q20 PR Newswire WILMINGTON, Del., Nov. 9, 2020 WILMINGTON, Del. , Nov. 9, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp....